BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 12521425)

  • 21. Women's perceptions and social barriers determine compliance to cervical screening: results from a population based study in India.
    Basu P; Sarkar S; Mukherjee S; Ghoshal M; Mittal S; Biswas S; Mandal R; Sankaranarayanan R
    Cancer Detect Prev; 2006; 30(4):369-74. PubMed ID: 16963194
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A review of smoking cessation services in women attending colposcopy clinics in Scotland.
    Rumbles AU; Nicholson SC; Court SJ
    J Obstet Gynaecol; 2012 Feb; 32(2):177-9. PubMed ID: 22296432
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Who defaults from colposcopy? A multi-centre, population-based, prospective cohort study of predictors of non-attendance for follow-up among women with low-grade abnormal cervical cytology.
    Sharp L; Cotton S; Thornton A; Gray N; Cruickshank M; Whynes D; Duncan I; Hammond R; Smart L; Little J
    Eur J Obstet Gynecol Reprod Biol; 2012 Dec; 165(2):318-25. PubMed ID: 22921577
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Management of women with abnormal cervical cytology: treatment patterns and associated costs in England and Wales.
    Martin-Hirsch P; Rash B; Martin A; Standaert B
    BJOG; 2007 Apr; 114(4):408-15. PubMed ID: 17378815
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Provision of contraceptive and related services by publicly funded family planning clinics, 2003.
    Lindberg LD; Frost JJ; Sten C; Dailard C
    Perspect Sex Reprod Health; 2006 Sep; 38(3):139-47. PubMed ID: 16963387
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A population-based study of primary care predictors of non-attendance for cervical screening.
    Webb R; Richardson J; Pickles A
    J Med Screen; 2004; 11(3):135-40. PubMed ID: 15333272
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Knowledge of the cervical cancer screening process among rural and urban illinois women undergoing colposcopy.
    Massad LS; Verhulst SJ; Hagemeyer M; Brady P
    J Low Genit Tract Dis; 2006 Oct; 10(4):252-5. PubMed ID: 17012992
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Screening for cervical carcinoma.
    van Leeuwen AW; de Nooijer P; Hop WC
    Cancer; 2005 Oct; 105(5):270-6. PubMed ID: 15937918
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characteristics of women refusing follow-up for tests or symptoms suggestive of breast cancer.
    Weinmann S; Taplin SH; Gilbert J; Beverly RK; Geiger AM; Yood MU; Mouchawar J; Manos MM; Zapka JG; Westbrook E; Barlow WE
    J Natl Cancer Inst Monogr; 2005; (35):33-8. PubMed ID: 16287883
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Communicating colposcopy results: what do patients and providers discuss?
    Pruitt SL; Parker PA; Follen M; Basen-Engquist K
    J Low Genit Tract Dis; 2008 Apr; 12(2):95-102. PubMed ID: 18369302
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An evaluation of economics and acceptability of screening for Chlamydia trachomatis infection, in women attending antenatal, abortion, colposcopy and family planning clinics in Scotland, UK.
    Norman JE; Wu O; Twaddle S; Macmillan S; McMillan L; Templeton A; McKenzie H; Noone A; Allardice G; Reid M
    BJOG; 2004 Nov; 111(11):1261-8. PubMed ID: 15521872
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Women's experiences of repeated HPV testing in the context of cervical cancer screening: a qualitative study.
    Waller J; McCaffery K; Kitchener H; Nazroo J; Wardle J
    Psychooncology; 2007 Mar; 16(3):196-204. PubMed ID: 16858719
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Assessment of follow-up for low-grade cytological abnormalities in the National Breast and Cervical Cancer Early Detection Program, 2000-2005.
    Benard VB; Howe W; Saraiya M; Helsel W; Lawson HW
    J Low Genit Tract Dis; 2008 Oct; 12(4):300-6. PubMed ID: 18820545
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevention of cervical cancer with screening programme in Branicevo District and cost-effectiveness analysis adjusted to the territory of the Republic of Serbia.
    Perovic S
    J BUON; 2009; 14(1):93-6. PubMed ID: 19373953
    [TBL] [Abstract][Full Text] [Related]  

  • 35. What predicts adherence to follow-up recommendations for abnormal Pap tests among older women?
    Coker AL; Eggleston KS; Meyer TE; Luchok K; Das IP
    Gynecol Oncol; 2007 Apr; 105(1):74-80. PubMed ID: 17157363
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Context of care and contraceptive method use.
    Boardman LA; Weitzen S; Lapane KL
    Womens Health Issues; 2004; 14(2):51-9. PubMed ID: 15120414
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Which demographic factors influence Pacific women's attendance at colposcopy clinics in New Zealand?
    McPherson G; Parmar P; Payne D; Fairbairn-Dunlop TP
    N Z Med J; 2021 Oct; 134(1543):69-78. PubMed ID: 34695078
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Attitudes and beliefs about cervical smear testing in ever-married Jordanian women.
    Amarin ZO; Badria LF; Obeidat BR
    East Mediterr Health J; 2008; 14(2):389-97. PubMed ID: 18561732
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Addressing Taiwan's high incidence of cervical cancer: factors associated with the Nation's low compliance with Papanicolaou screening in Taiwan.
    Liao CC; Wang HY; Lin RS; Hsieh CY; Sung FC
    Public Health; 2006 Dec; 120(12):1170-6. PubMed ID: 17074376
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Demographic, risk factor, and knowledge differences between Latinas and non-Latinas referred to colposcopy.
    del Carmen MG; Findley M; Muzikansky A; Roche M; Verrill CL; Horowitz N; Seiden MV
    Gynecol Oncol; 2007 Jan; 104(1):70-6. PubMed ID: 16949138
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.